# Efficacy of PJS-539 for Adult Patients With COVID-19.

> **NCT05008393** · PHASE2 · COMPLETED · sponsor: **Hospital do Coracao** · enrollment: 153 (actual)

## Conditions studied

- Covid19
- COVID-19 Pneumonia

## Interventions

- **DRUG:** PJS-539 Dose 1
- **DRUG:** PJS-539 Dose 2
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05008393
- **Lead sponsor:** Hospital do Coracao
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-25
- **Primary completion:** 2022-02-03
- **Final completion:** 2022-03-04
- **Target enrollment:** 153 (ACTUAL)
- **Last updated:** 2022-04-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05008393

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05008393, "Efficacy of PJS-539 for Adult Patients With COVID-19.". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05008393. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*